Brain Natriuretic Peptide in the Management of Heart Failure

This publication has 125 references indexed in Scilit:

• Retrospective analysis of thecost-effectiveness of using plasmabrain natriuretic peptide inscreening for left ventricularsystolic dysfunction in the general population
  Journal of the American College of Cardiology, 2003
• The Effect of Spironolactone on Morbidity and Mortality in Patients with Severe Heart Failure
  New England Journal of Medicine, 1999
• Digitalis increases brain natriuretic peptide in patients with severe congestive heart failure
  American Heart Journal, 1997
• Diagnostic Value of B-Type Natriuretic Peptide Concentrations in Patients With Acute Myocardial Infarction
  Published by Elsevier ,1996
• Comparison of atrial natriuretic peptide, B-type natriuretic peptide, and N-terminal proatrial natriuretic peptide as indicators of left ventricular systolic dysfunction
  The American Journal of Cardiology, 1996
• Effect of low dose beta blockers on atrial and ventricular (B type) natriuretic factor in heart failure: a double blind, randomised comparison of metoprolol and a third generation vasodilating beta blocker.
  Heart, 1995
• Detection of left ventricular dysfunction after acute myocardial infarction: comparison of clinical, echocardiographic, and neurohormonal methods.
  Heart, 1994
• Plasma brain natriuretic peptide as an indicator for angiotensin-converting-enzyme inhibition after myocardial infarction
  Published by Elsevier ,1993
• Effects of Enalapril on Mortality in Severe Congestive Heart Failure
  New England Journal of Medicine, 1987
• Plasma Norepinephrine as a Guide to Prognosis in Patients with Chronic Congestive Heart Failure
  New England Journal of Medicine, 1984